Marketresearchnews

Monday, 18 November 2019

Blood Collection Market to Observe Significant Growth by 2019

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Blood Collection Market Research Report – Global Forecast till 2023” Gives industry size, top players and worldwide demand

Market Scenario:

Blood collection plays an important role in the treatment of patients. It persists as a diagnostic tool in laboratory medicine. In most of the cases, blood is usually collected to perform a variety of laboratory tests. Among all the types of blood collection devices, Capillary Blood Collection is simple and relatively painless procedure for clinical testing.

Global Blood Collection Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 7.46 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7013

According to the World Health Organization (WHO), there are over 35 Million healthcare workers and these workers face an increased risk of infection from blood-borne pathogens simply because of their exposure to blood and other body fluids. However, blood contamination and injury caused by blood collection devices can restrain the market growth over the assessment period.

Rising demand for early diagnosis of chronic conditions is one of the key factors driving the blood collection market. According to the Centres for Disease Control and Prevention (CDC), in 2017 nearly 30.3 million people had diabetes out of which 23.1 million people were diagnosed with diabetes while 7.2 million people remain undiagnosed in the United States. Various other factors such as rising awareness about blood sampling, favourable medical device regulation, developing healthcare infrastructure, increasing research & development activities related to healthcare and favourable reimbursement and funding policies are also expected to propel the growth of the market.

However, the injury caused during blood collection, blood contaminations, and other complications can hinder the market growth over the forecast period.

There are several potential complications related to blood collection procedure such as, Haematoma or excessive bleeding, arteriospasm or involuntary contraction of the artery, nerve damage, fainting or a vasovagal response, and others.

Key players:

BD,
Medtronic,
Terumo,
Haemonetics,
Fresenius,
Nipro Medical,
Kawasumi Laboratories,
L. Medical,
Greiner Holding,
Grifols,
Braun Melsungen AG,
Thermo Fisher Scientific Inc.,
HTL-STREFA S.A.,
Sarstedt AG & Co

Segmentation:The Global Blood Collection Market has been segmented into type of blood collection, product, method, and end user.The market, on the basis of type of blood collection, has been segmented into capillary blood collection, venous blood collection, and vacuum blood collection.The market, by product, has been segmented into blood collection devices, blood collection tubes and collector, needles and syringes, warming devices, blood bags, lancets, and others. The blood collection tubes and collector segment is further classified as serum collection tubes, and plasma or whole blood collection tubes. The plasma or whole blood collection tubes segment includes EDTA tubes, heparin tubes, coagulation tubes, glucose tubes, and ESR tubes. The market, by method, has been segmented into automated blood collection and manual blood collection.

The market, by end user, has been segmented into hospitals & clinics, diagnostic centres and pathology laboratories, home diagnostics, blood banks, and others. The hospitals & clinics segment is anticipated to hold the largest market share owing to the increasing cases of chronic conditions. The diagnostic centres and pathology laboratories are expected to grow at the highest CAGR owing to the ongoing research on better blood sampling approaches.The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The blood collection market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European Blood Collection Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Blood Collection Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The blood collection market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures Segmented by Type of blood collection (capillary, venous, vacuum), by product (blood collection devices, blood collection tubes, needles and syringes, lancets), by method (automated, manual), end user @ https://www.marketresearchfuture.com/reports/blood-collection-market-7013

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Animal Genetics Market - Granular Market Report and Review, 2019

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Animal Genetics Market Research Report – Global Forecast till 2023” Gives industry size, top players and worldwide demand

Market Scenario:

Animal genetics is a branch of genetics that pacts with the study of genetic variation and inheritance, primarily for domestic and wild animals. The Animal Genetics Market is expected to witness tremendous growth owing to as increased adoption of genetic services to prevent genetic diseases and business loss, and rising acceptance of advanced genetic technologies. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for specific breeding programs for breeds with inferior economic performance, and economic sustainability in local breeds is likely to curb the market growth during the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7004

For the commercial level, animal genetics is used for services such as DNA typing, genetic disease testing, and genetic trait testing. This methodology uses hybrid population, ontogenetic, and cytological studies for determining the genetic hybridizations. For instance, a genetically modified cow might be able to produce more milk and can be less prone to common cattle diseases, such as clostridial disease, bovine respiratory disease complex, etc., thus, effectively increasing overall profit of the cattle farmers.

The Global Animal Genetics Market size is projected to register a CAGR of 8.4% over the forecast period.

The key factor responsible for influencing this market is increasing consumption of animal-derived protein, growing global population and rapid urbanization, and growing focus on identifying superior breeds have aided the growth of the toxicology testing market. However, factors such as, the high cost of animal testing, stringent regulatory framework for genetic engineering, and lack of skilled professionals and are expected to restrict the market growth during the forecast period.

Key players:

Neogen Corporation (US),
Genus (UK),
URUS (US),
EW Group (Germany),
Groupe Grimaud (France),
CRV Holding B.V. (The Netherland),
Topigs Norsvin (Netherlands),
Zoetis (US),
Envigo (US)
Hendrix Genetics BV (The Netherland),
Animal Genetics (US),
Alta Genetics (US),
vetGen (US)

Segmentation:The Global Animal Genetics Market is segmented into animal genetic products, services, and end-user. The Animal Genetics Market, by animal genetic products, the market is segmented into genetic materials and live animals. The live animals are further bifurcated into poultry, bovine, porcine, canine and others. The genetic materials are sub-segmented into semen and embryo. On the basis of services, the animal genetics market is bifurcated into genetic disease tests, DNA typing, gene trait tests, and others. On the basis of end-user, the market is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures Segmented by Animal Genetic Products (Genetic Materials, Live Animals), Services (Genetic Disease Tests, DNA Typing, Gene Trait Tests), End-User (Veterinary Hospitals & Clinics, Diagnostic Centres) @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hemorrhoids Treatment Market - Granular Market Report and Review, 2019

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Hemorrhoids Treatment Market Research Report – Global Forecast till 2023” Gives industry size, top players and worldwide demand

Market Scenario:

The prevalence of hemorrhoids is found particularly between the age of 45 and 65, both in men and women. However, only a small percentage of the affected population seek any form of medical treatment like medication or surgery and instead opt for relief pills purchased from pharmacies.

Hemorrhoid is a highly uncomfortable disorder which is also known as piles. The condition is so subtle yet dangerous that most people under the age of fifty are unaware of the same. Hemorrhoids are inflamed, swollen veins situated in the anal canal and causes a strong sense of irritation in the form of both pain and itchiness. Patients who suffer from the same condition seek relief from a variety of products, boasting both negatives and positives. Direct products like wipes, creams, pads, and suppositories are highly effective at offering temporary period of relief. However, it is not effective enough for permanent treatments.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6999

According to the latest report by the team of Market Research Future (MRFR), the global hemorrhoids treatment market is expected to grow at a decent rate of 7.1% during the forecast period of 2018 to 2023. The market growth is influenced by numerous factors like the increasing prevalence of lifestyle-based diseases, growing demand for treatment, an increasing demand for reducing infections & complications relating to hemorrhoids, and an increasing number of surgeries. The growing old-age population is also one of the key contributors to the global demand for hemorrhoids treatment. However, lack of awareness and hesitancy towards medical treatment due to the feeling of embarrassment stands out as a key constraint to the growth of the global market.

Market Segmentation

The global hemorrhoids treatment market segmentation is based in terms of route of administration, treatment type, distribution channel, and region.

By treatment type, the market segments into drugs, surgical procedures, and non-surgical procedures. The drugs segment is further segmented into NSAIDs, laxatives, and herbals. The non-surgical procedures narrows down into cryotherapy, band litigation, and sclerotherapy.

By route of administration, the market divides into oral and topical agents.

By distribution channel, the market includes hospital pharmacies, retail pharmacies, online pharmacies, and others.

Regional Analysis

The regional segmentation of the global hemorrhoids market covers four major regions globally, namely Asia Pacific, Europe, the Americas, and the Middle East & Africa.

The Americas hold the maximum share of the market as per the global standings. The dominance of the region can be attributed to the huge patient population, high expenditure in the healthcare sector, and a well-established technology. The regional market for hemorrhoids treatment is expected to continue its dominance in the forthcoming years.

Europe accounts for the second largest market globally following the Americas. The European region is segmented into key regions, namely Western and Eastern Europe. The Western European region consists of countries like the UK, Germany, and France. Factors that primarily push the market in this region are the lack of any physical exercise, sedentary lifestyle, obesity, alcoholism, poor fiber intake in diet, etc.

Asia Pacific is slated to be the fastest growing regions in hemorrhoids. The growth in this region can be attributed to factors like the increasing demand for better diagnostic devices, rapidly improving technologies, better and safe therapeutic approach, and the presence of a massive talent pool.

Competitive Landscape

The global hemorrhoids treatment market holds a number of key players like Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company, Abbott Laboratories, Boston Scientific Corporation, GlaxoSmithKline, Pfizer Inc., AstraZeneca PLC, CONMED Corporation, Taro Pharmaceuticals Inc., Astra Zeneca, Olympus Corporation, Cook Medical, Glenmark Pharmaceuticals Bayer AG, Teva Pharmaceutical Industries Ltd, and others.

13^th March 2019, Organization de Scalene announced recently the launch of Cryocure. Cryocure is an affordable medical device that is used to treat piles without any need for surgery.

8^th April 2019, Trifecta Pharmaceuticals, one of the leading developers, distributors, and manufacturers of specialty OTC topical creams, gels, and ointments announced today about its distribution partnership with Walmart. The move will see Mayinglong, a hemorrhoid treatment ointment, being available on the shelves of the leading departmental store.

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures Segmented by Treatment type (drugs, non-surgical procedures, surgical procedures), Route of administration (oral, topical agents) Distribution channel (retail pharmacies) @ https://www.marketresearchfuture.com/reports/hemorrhoids-treatment-market-6999

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Clear Aligners Market Volume Forecast and Value Chain Analysis 2019

The global clear aligners market is expected to exhibit a robust CAGR of 20.80% over the forecast period from 2018 to 2023, according to the latest market research report from Market Research Future (MRFR). The global clear aligners market is driven mainly by the growing demand for dental corrective measures that don’t spoil the visual aesthetics of the individual’s face. Conventional braces can be an eyesore due to their distinctive appearance. The clear aligners market has been driven primarily by the growing recognition of this problem by the medical community, which has led to extensive product innovation efforts to come up with relevant solutions.

The increasing need for dental corrective tools around the world is likely to be a major driver for the global clear aligners market over the forecast period. Growing prevalence of dental alignment problems is likely to be a major driver for the clear aligners market over the forecast period. The dentistry field has grown exponentially in the last few years due to the growing demand for dental procedures and the increasing disposable income of consumers, which has led to a corresponding increase in demand for more advanced, more sophisticated methods and tools for dental corrective procedures. Rapid product innovation is likely to be a major driver for the global clear aligners market over the forecast period due to the need for developing stronger and more comfortable clear aligner products that can get the job done without making it painful or uncomfortable for the patient.

The growing incorporation of dental procedures in health insurance policies is also likely to drive the global clear aligners market over the forecast period, as dental procedures have conventionally been left out of healthcare plans and are only now starting to get included in wide-ranging healthcare policies due to the growing awareness about their utility and need.

Competitive Analysis:

Leading players in the global clear aligners market include Institut Straumann AG, Align Technology Inc., Clarus, Dentsply Sirona, Danaher Corporation, and 3M. Acquisition of smaller market players in order to expand one’s market presence is a popular tactic in the global clear aligners market and is likely to remain highly popular over the forecast period due to the potential of the strategy in terms of adding to a company’s product portfolio as well as geographical presence. Acquiring or merging with smaller players in emerging regions is likely to remain a popular competitive strategy for players in the global clear aligners market over the forecast period. Align Technology Inc. is the leading market player and accounts for more than 80% of the market. The company’s dominance is due to its widespread geographical coverage, including North America, Europe, Latin America, as well as parts of the Middle East and Africa.

In February 2019, Ormco Corp. launched SmartArch, an advanced archwire product, and gave the first glimpse of its Spark clear aligner, which is expected to be launched in 2019.

Segmentation:

The global clear aligners market is segmented on the basis of product type, age, distribution channel, and region.

By product type, the global clear aligners market is segmented into hard, medium, and soft clear aligners. Hard clear aligners are the popular market segment and are likely to exhibit the fastest growth over the forecast period at a CAGR of 21.04%.

By age, the clear aligner market is divided into adult and teenagers. The adult segment holds the larger market share and is likely to rise to a valuation of USD 2,996.59 million over the forecast period from 2018 to 2023.

By distribution channel, the global clear aligners market is segmented into direct sales, laboratories, and others. Direct sales accounted for 78% of the global clear aligners market in 2017 and are likely to account for the dominant market share over the forecast period, rising to a value of USD 3,185.47 million by the end of the forecast period.

Regional Analysis:

The Americas segment holds the largest share in the global clear aligners market and is likely to rise to a valuation of USD 2,161.22 million by the end of the forecast period. The growing importance of aesthetics in dentistry procedures in North America is likely to be a major driver for the clear aligners market in the region over the forecast period.

Browse Complete Premium Research Report Enabled with Tables and Figures Segmented By Product Type (Hard, Medium and Soft), Age (Adult and Teenager), Distribution Channel (Direct Sales and Laboratories) and Region @ https://www.marketresearchfuture.com/reports/clear-aligners-market-6974

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Endovascular Aneurysm Repair Devices Market Growth and Restrain Factors Analysis By 2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Endovascular Aneurysm Repair Devices Market Research Report – Forecast to 2023” Gives industry size, top players and worldwide demand

Market Scenario

Endovascular aneurysm repair (EVAR) is a collective term for all treatments that are directed to surgically cure an aortic aneurysm located in the patient’s abdomen. Factors such as reduced recovery times, low-cost hospitalization charges, and technological advancements in repair devices are expected to drive the growth of the market.

The global endovascular aneurysm repair devices market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in April 2018, Vascutek Ltd. and Bolton Medical, subsidiaries of Terumo Corporation, have merged into Terumo Aortic. Combining the aortic companies into a single business, Terumo Corporation aims to grow its presence in the aortic and vascular implants market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6485

It is estimated that the global endovascular aneurysm repair devices market is expected to record a CAGR ~ 6.4 % during the forecast period of 2018 to 2023.

Segmentation

The global endovascular aneurysm repair devices market has been segmented into indication, site, anatomy, and products.

The market, on the basis of indication, has been segmented into the abdominal aortic aneurysm, thoracic aortic aneurysm and others.

The market, based on thoracic aortic aneurysm, has been further segmented into ascending aortic aneurysm, descending aortic aneurysm, thoracoabdominal aortic aneurysm, and thoracic arch aortic aneurysm.

The market, on the basis of the site, has been segmented into infrarenal and pararenal.

The market, based on pararenal site, has been sub-segmented into juxtarenal and suprarenal.

The market, on the basis of anatomy, has been segmented into traditional and complex.

The market, on the basis of products, has been segmented into percutaneous EVAR, fenestrated EVAR, aortic stents and TAA grafts, and others.

Regional Market Summary

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The endovascular aneurysm repair devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The Americas is expected to dominate the global endovascular aneurysm repair devices market owing to increasing geriatric population, and well-developed healthcare sector. With the increase in the geriatric population, the prevalence of aneurysms is also expected to rise. The Centers for Disease Control and Prevention (CDC) ranks abdominal aortic aneurysm as one of the top 15 causes of mortality in the United States, but only for those between 85 and 89 years. According to the Centers for Disease Control and Prevention, aortic aneurysms were the primary cause of 9,863 deaths in 2014 in the US.

Europe is expected to hold the second largest position in the global endovascular aneurysm repair devices market. The market growth in this region is attributed to the growing prevalence of aneurysms, availability of funds for research, and favorable reimbursement scenario.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to the growing government initiatives for the healthcare sector.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies.

Browse Complete 100 Pages Premium Research Report Enabled with 110 Respective Tables and Figures Segmented By Indication (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, and Others), by Site (Infrarenal and Pararenal), by Anatomy, and by Products (Percutaneous EVAR and Others) @ https://www.marketresearchfuture.com/reports/endovascular-aneurysm-repair-devices-market-6485

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Malaria Diagnostics Market Expected to Grow at High CAGR during Forecast Period 2019 – 2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Malaria Diagnostics Market Research Report – Forecast to 2023” Gives industry size, top players and worldwide demand

Malaria is a serious life-threatening disease caused by a parasite, transmitted by the bite of infected anopheles mosquitoes. Infected mosquitoes transport the Plasmodium parasite. When the infected mosquito bites you, the parasite is released into your bloodstream. Once the human body becomes the host for the parasite it travels to the liver and matures. After some days, the mature parasite enters the bloodstream and starts to infect red blood cells (RBC). Humans suffering from malaria frequently experience fever, headache, weakness, vomiting

A major factor influencing this growth is the increasing advancements in technology related to diagnostic tools and the proliferating demand for such treatments in malaria-endemic countries. Other factors driving the market growth are rising support from the government in terms of investment funds and an increase in the collaboration between the research centers and the industry. Malaria diagnostic tests play a significant role in identifying malarial cases, which thereby boosts the growth of the overall malaria diagnostic market.

However, the lack of precise monitoring standards at developing nations, acts as a major factor constraining the market. The lack of awareness among emerging nations and work regulatory framework is of particular concern for both manufacturers and healthcare providers.

Key Players

Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.

Segmentation

The global malaria diagnostics market has been segmented on the basis of technology and end-user.

On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).

On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European malaria diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The malaria diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria diagnostics market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

In the malaria diagnostics market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. In 2016, global governments of malaria-endemic countries have invested USD 2.7 billion in malaria control and elimination efforts. The US was the largest contributor by providing USD 1 billion for the eradication of malaria.

The European market is expected to hold the least share due to the growing number of malaria-free countries in the region.

The market in the Middle East and Africa is expected to account for the smallest share of the global malaria diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Sub-Saharan Africa remains to bring an excessively high share of the global malaria burden on the Middle Eastern and African market. the region was home to 90% of malaria incidences and 92% of malaria deaths in 2015

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism. The Asia-Pacific remains to be the second largest burden of malaria globally with 22 malaria-endemic countries accounting for roughly 28 million cases and 45,000 deaths every year. The WHO figures say that in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the highest malaria burden accounting for 89% of all malaria cases in the region.

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures Segmented by Technique (Rapid Diagnostic Tests, Microscopy and Molecular Diagnostic Tests, and Others) and by End-Users (Hospitals, Clinics, and Others) @ https://www.marketresearchfuture.com/reports/malaria-diagnostics-market-6432

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Saturday, 16 November 2019

Palliative Care Market 2019 - Current and Future Plans 2023

Market Research Future has recently declared the expansion of a New Research Study to its thorough collection of Research Reports “Palliative Care Market Research Report – Forecast to 2023”.

Market Scenario

Palliative care helps to improve the quality of life of patients and their families facing the problems of serious illness. The main focus of Palliative care is to provide relief from symptoms and stress of a serious illness. Their main goal is to improve the quality of life for both the patient and the family. Palliative care treats people living with a serious illness such as cancer, cardiac diseases such as congestive heath failure, kidney failure, Alzheimer’s and many more. It improves the quality of life of the patient and supports the primary physician, patient, and family. In last 15 years, the Palliative care market has a stunning growth and the factors that have led to the growth of this market are growing the aging population, increase in chronic life-threatening disease, initiative taken by the government and non- profit organization, and rise in government funding.

Global Palliative Care market is expected to grow during the forecast period at a CAGR ~8.1 %.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6336

Increasing incidence of diseases such as cancer, cardiovascular and infective disease are some of the drivers responsible for the market growth of global palliative care market. Other factors such as a growing number of palliative care centers worldwide, expanding aging demographics, increasing number of qualified physicians for palliative care are responsible for the rise in the global palliative market. The main object of palliative care is to enhance personal satisfaction for both the patient and family. This palliative care can be provided at any age and at any phase in a genuine ailment and can be furnished alongside remedial treatment.

However, the high cost of treatment, misuse of funding and lack of awareness are some of the factors which are hampering the growth of the market during the forecast period.

But the high cost of treatment, less private or public funding to hospital facilities and other medical centers can be a major restraint for the growth of the global palliative care market.

Key Players

Vitas Healthcare Corporation
Skilled Healthcare Group Incorporated
Sunrise Senior Living LLC
Kindred Healthcare Incorporated
Gentiva Health Services Incorporated
Home Instead Senior Care Incorporated
Amedisys Incorporated
Genesis HealthCare Corporation

Segmentation

The Global Palliative Care Market is segmented into types such as private residence care, hospice inpatient care, hospital inpatient care, nursing home and residential facility care and others. On the basis of application, the market is further segmented into cancer, cardiac diseases such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), kidney failure, Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS) and many more. On basis of end-user, the market is further segmented into hospitals, home care settings, palliative care centers, long-term care centers & rehabilitation centers.

Regional Analysis

In terms of market value, North America will dominate the Palliative care market during the forecast period. Increasing incidences of life-threatening illness such as cancer, cardiovascular diseases, Alzheimer’s disease, kidney failure, chronic obstructive pulmonary disease and many more are some of the factors which are responsible for the growth of the market during the forecast period. In 2015 on average 90 % of US hospitals containing 300 beds or more provide Palliative care services to their patients. This has led to the growth of the market in coming years. The European market is expected to be the second-largest Palliative care market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of Palliative care centers worldwide, extending application for homecare, increasing number of qualified physicians for Palliative care center and expanding aging demographics are some of the factors responsible for the rise in the global Palliative care market. Asia-Pacific is expected to be the fastest-growing Palliative care market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the global Palliative care market by producing a cost-effective treatment that is high in demand in local as well as in the global market. The market in the Middle East and Africa is expected to account for the smallest share in the global Palliative care market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

The market has been segmented, by region, into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Global Palliative Care Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Global Palliative Care Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Global Palliative Care Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Palliative care market in the Middle East and Africa has been segmented into the Middle East and Africa.

Browse Complete Report Segmented by Type (Private Resident Care, Hospital Inpatient Care, Nursing Home and Residential Facility Center, and Others), by Application (Cancer, Kidney Failure, and Others), by End-User (Hospitals, Palliative Care Centers, and Others) @ https://www.marketresearchfuture.com/reports/palliative-care-market-6336

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com